Entangling of Peptide Nanofibers Reduces the Invasiveness of SARS-CoV-2

Adv Healthc Mater. 2023 Sep;12(24):e2300673. doi: 10.1002/adhm.202300673. Epub 2023 May 14.

Abstract

The viral spike (S) protein on the surface of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to angiotensin-converting enzyme 2 (ACE2) receptors on the host cells, facilitating its entry and infection. Here, functionalized nanofibers targeting the S protein with peptide sequences of IRQFFKK, WVHFYHK and NSGGSVH, which are screened from a high-throughput one-bead one-compound screening strategy, are designed and prepared. The flexible nanofibers support multiple binding sites and efficiently entangle SARS-CoV-2, forming a nanofibrous network that blocks the interaction between the S protein of SARS-CoV-2 and the ACE2 on host cells, and efficiently reduce the invasiveness of SARS-CoV-2. In summary, nanofibers entangling represents a smart nanomedicine for the prevention of SARS-CoV-2.

Keywords: anti-virals; biomimetics; nanofibers; peptides; self-assembly.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme 2 / chemistry
  • COVID-19*
  • Humans
  • Nanofibers*
  • Peptides
  • Protein Binding
  • SARS-CoV-2

Substances

  • Angiotensin-Converting Enzyme 2
  • Peptides